Gastroenterology & Hepatology Patient Care

patient care

Quality Care Across Communities

Cutting-edge therapeutics for all forms of digestive and liver diseases at clinics throughout Michigan

We provide the highest quality of care and offer the most cutting-edge therapeutics available. Our faculty are also leaders in their respective areas of research, conducting and participating in many pharmaceutical clinical investigations. The innovative research conducted by our physicians and faculty has paved the way for more effective methods of prevention, diagnosis and treatment of gastrointestinal diseases.

The Department of Gastroenterology & Hepatology physicians, along with GI radiologists, surgeons, physician assistants, nurse practitioners, nurses and dietitians, provide care for all forms of digestive and liver diseases at numerous clinics in Ann Arbor, surrounding communities and the state of Michigan. In addition, we have several specialty, multidisciplinary programs including the Comprehensive Pancreas Program, Esophageal Disorders Program, Functional Bowel Disorders Program, Hepatology Program, IBD Program, Interventional Endoscopy Program and Michigan Bowel Control Program.

Find a Doctor

Find a doctor who meets your needs

Find a Clinic

Find a clinic near you

Patient & Visitor Guide

Find additional information and resources for patient and visitors

For Referring Providers

Connect with M-LINE for referral and consultation information

dept_surg_medical_campus_aerial
Individualized Care

Gastrointestinal Care at U-M Health

We are home to one of the largest digestive health and liver disease programs in the country. Our highly-trained specialists are dedicated to innovative and effective treatments for every single patient. Find the treatment that's right for you.

Gastroenterology Services

Featured News & Stories

 See all news particles forming colorful in intestines
Health Lab

IBS treatment response predicted by gut microbiome in new study

A Michigan Medicine study finds the low FODMAP diet and the antibiotic rifaximin provided similar and significant relief for patients with irritable bowel syndrome with diarrhea (IBS-D).
 red cells clustered together inside body black light up blue see through
Health Lab

Understanding esophageal cancer

In this Q&A, a Michigan Medicine doctor talks about esophageal cancer, its signs and risk factors to know.
 Man in a blue pullover against the background of Michigan Stadium
Health Lab

Thriving after a rectal cancer diagnosis

Kyle Kipke was diagnosed with rectal cancer and received chemotherapy and radiation as treatment at Michigan Medicine.
 close up microscopic grey close up
Health Lab

FDA-approved cancer drug fedratinib reshapes how cell organelles communicate, providing new therapeutic avenues

University of Michigan researchers found that the FDA-approved drug fedratinib can lead to endoplasmic reticulum and mitochondria contact site formation, providing a potential therapeutic avenue.
 intestines red with red dot
Health Lab

Colorectal cancer is no longer just a disease of older adults

With colorectal (CRC) on the rise in younger patients, a specialist in gastroenterology and human genetics discusses why that may be and what to look for.
 microscope drawing yellow navy
Health Lab

Glucose drives STAT3 activation in colorectal cancer cells, leading to tumor growth

University of Michigan researchers have shown that glucose levels sustain the increased STAT3 activation in colorectal cancer cells. Their findings suggest that targeting glucose metabolism could inhibit STAT3, leading to novel therapeutic strategies.